| Date | Subject |
|---|
08/6/2021
12:28 | spin doctor: 1'45": 'We've got a strong pipeline'. Said with a big smile.
From 4': industry-wide comments, OMIP ambitions and 'we keep our multiples within directors' expectations' which as I recollect are 8-12x.
I'd be surprised if there wasn't a raise in the next 12 months, to help move OMIP from nanocap status.
https://www.proactiveinvestors.co.uk/companies/news/951581/one-media-buys-interest-in-royalties-of-legendary-80s-music-producer-951581.html
|
28/5/2021
11:00 | spin doctor: As the OMIP CEO asks on Twitter, what is wrong with this announcement?
http://otp.investis.com/clients/uk/onemedia1/rns/regulatory-story.aspx?cid=608&newsid=1478804
Probably sold down that 2.98% by now, IMO.
|
04/5/2021
20:37 | spin doctor: This deal gives real credibility to the OMIP offer, of Harmony IP + TCAT. More deals will surely follow.
Caring for coconuts! As Kid says below:
“One Media is a natural home for my music because they are focused on digital; nowadays there are hundreds of platforms,” said Darnell. “Kid Creole has to look after his Coconuts’ way into the future and that’s why I’ve done the deal.”
https://www.rte.ie/entertainment/2021/0504/1213534-kid-creole-sells-back-catalogue-of-songs-for-cash/
https://www.theguardian.com/music/2021/may/04/red-hot-chili-peppers-sell-hipgnosis
|
04/5/2021
09:12 | spin doctor: One thing we can be sure. OMIP will not have overpaid.
Maybe this is a small deal, but more will come in time, and the fundamentals look far more attractive than the big players IMO.
|
14/4/2021
19:35 | spin doctor: Yes Yump.
I don't see any media froth that would have prompted very short term trades. Nor however do I see any trades of a scale suggesting Institutional buying. The OMIP team have however been speaking to instis and PIs over the last week.
Has anyone downloaded the latest Cenkos note? Free to access after registration at https://www.research-tree.com/
SONG value their catalogue through a dcf model. Apply that, or an earnings multiple approach (as Cenkos have done) to the OMIP assets, and you get to a fair value per share of 17.6p with a multiple of 10x. And that's without deployment of the £5M or so cash.
|
22/3/2021
09:19 | spin doctor: Results imminent.
Whilst waiting, FWIW I note that OMIP is included in the (short...) list of companies meeting Joel Greenblatt's 'magic formula'.
https://www.research-tree.com/screen/joel-greenblatt-s-magic-formula-style
But heck, we knew OMIP is cheap on historic criteria.
Results have largely been flagged in the trading update. It will obv be interesting to see how deployment of last year's cash inflow is going. Perhaps slowly - my sense is that this team will not overpay for 'in perpetuity' cash streams.
|
22/2/2021
11:25 | spin doctor: Yet another example of how streaming is entering the financial mainstream:
https://www.telegraph.co.uk/business/2021/02/21/bmg-boss-artists-need-smart-not-sign-stupid-deals/
And OMIP offers a smart solution.
OMIP, as a nano-cap, is clearly off the radar for the moment. But results and news to come as the cash is deployed.
|
31/1/2021
15:54 | yump: I try not to get too excited, but the noises from OMIP and the Take That purchase, make me think it might be like a very small version of SONG, except OMIP has an additional strategy of adding value to the rights, because of enhanced tracking.
So maybe in a few years, we will be getting generous dividends, plus capital growth as a result of OMIP actually increasing the value of the rights. That would be evident from increasing returns.
|
19/1/2021
09:20 | yump: I imagine this wil get a bit of coverage over the next few weeks.
Interesting that SONG must have paid some premium multiples for a lot of their catalogues, but its not that clear how they are going to improve the return, unless I’ve missed some explanations.
With OMIP, although they’ve now bought something that presumably had a full valuation, they have developed expertise in adding value. Perhaps they can also earn well from licencing TCAT to these larger businesses.
It looks like the returns from OMIP will not be fully dependent on paying dividends like SONG, but on business value growth, as a result of adding value to the royalty flow.
|
17/1/2021
13:43 | nextlink: Michael Infante has been in this industry for over 30 years.
He has never had the funds to buy major Artists music rights.
In consequence he has had to buy carefully and has not,I believe, overpaid.
Looking at Hipgnosis in particular.
They only appeared in July 2018 with Merck Mercuriadis as their
music expert, clearly a talented and able individual.
Given the business model.
Large Capital Investment to acquire Music Rights and a long
period to recover that expenditure and later hopefully profit
from it.
OMIP results are in around 10 weeks and Hipgnosis probably early July.
OMIP - Low Market Cap, over £6 million in cash - exciting possiblities
with TCAT
SONG - High Market Cap - 100X OMIP, Heavy Debt, as at 6th January 2021
The Company has entered into an agreement with a syndicated group of lenders, with JPMorgan Chase Bank as Lead Arranger, to increase its Revolving Credit Facility from $400 million to $600 million. The Company may request an increase in the Revolving Credit Facility commitment by a further $150 million subject to certain conditions.
I cannot help but think that Hipgnosis will be seen to have overpaid.
That will only be confirmed when we have a few years future results.
|
PLUS1
